DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42(NASDAQ:DHCNI) stock Fundamental Analysis

Fundamental Rating

Overall DHCNI gets a fundamental rating of 2 out of 10. We evaluated DHCNI against 129 industry peers in the Diversified REITs industry. Both the profitability and financial health of DHCNI have multiple concerns. DHCNI is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year DHCNI has reported negative net income.

DHCNI had a positive operating cash flow in the past year.

In the past 5 years DHCNI reported 4 times negative net income.

In multiple years DHCNI reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of DHCNI (-5.86%) is worse than 86.05% of its industry peers.

DHCNI has a worse Return On Equity (-15.04%) than 82.17% of its industry peers.

		Industry Rank	Sector Rank
ROA	-5.86%
ROE	-15.04%
ROIC	N/A

ROA(3y)-4.29%

ROA(5y)-2.48%

ROE(3y)-10.69%

ROE(5y)-6.22%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 17.75%, DHCNI is not doing good in the industry: 93.80% of the companies in the same industry are doing better.

In the last couple of years the Gross Margin of DHCNI has declined.

DHCNI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	17.75%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.33%

GM growth 5Y-20.05%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DHCNI does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for DHCNI has been increased compared to 1 year ago.

Compared to 5 years ago, DHCNI has more shares outstanding

The debt/assets ratio for DHCNI is higher compared to a year ago.

2.2 Solvency

DHCNI has an Altman-Z score of 0.31. This is a bad value and indicates that DHCNI is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 0.31, DHCNI is doing worse than 62.02% of the companies in the same industry.

DHCNI has a Debt/Equity ratio of 1.44. This is a high value indicating a heavy dependency on external financing.

The Debt to Equity ratio of DHCNI (1.44) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	1.44
Debt/FCF	N/A
Altman-Z	0.31

ROIC/WACCN/A

WACC7.08%

2.3 Liquidity

DHCNI has a Current Ratio of 7.40. This indicates that DHCNI is financially healthy and has no problem in meeting its short term obligations.

DHCNI's Current ratio of 7.40 is amongst the best of the industry. DHCNI outperforms 96.12% of its industry peers.

DHCNI has a Quick Ratio of 7.40. This indicates that DHCNI is financially healthy and has no problem in meeting its short term obligations.

The Quick ratio of DHCNI (7.40) is better than 96.12% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	7.4
Quick Ratio	7.4

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

DHCNI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.62%, which is quite impressive.

The Revenue has been growing slightly by 5.33% in the past year.

Measured over the past years, DHCNI shows a small growth in Revenue. The Revenue has been growing by 7.53% on average per year.

EPS 1Y (TTM)39.62%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%113.89%

Revenue 1Y (TTM)5.33%

Revenue growth 3Y2.63%

Revenue growth 5Y7.53%

Sales Q2Q%4.34%

3.2 Future

The Earnings Per Share is expected to grow by 13.50% on average over the next years. This is quite good.

Based on estimates for the next years, DHCNI will show a small growth in Revenue. The Revenue will grow by 5.67% on average per year.

EPS Next Y40.36%

EPS Next 2Y13.5%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year4.86%

Revenue Next 2Y5.67%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DHCNI. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DHCNI. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DHCNI is valued expensively inside the industry as 93.02% of the companies are valued cheaper.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	25.75

4.3 Compensation for Growth

A more expensive valuation may be justified as DHCNI's earnings are expected to grow with 13.50% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y13.5%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

DHCNI has a Yearly Dividend Yield of 1.27%.

Compared to an average industry Dividend Yield of 6.80, DHCNI's dividend is way lower than its industry peers. On top of this 92.25% of the companies listed in the same industry pay a better dividend than DHCNI!

With a Dividend Yield of 1.27, DHCNI pays less dividend than the S&P500 average, which is at 2.39.

		Industry Rank	Sector Rank
Dividend Yield	1.27%

5.2 History

The dividend of DHCNI decreases each year by -45.60%.

DHCNI has been paying a dividend for over 5 years, so it has already some track record.

DHCNI has not decreased its dividend in the last 3 years.

Dividend Growth(5Y)-45.6%

Div Incr Years0

Div Non Decr Years3

5.3 Sustainability

DHCNI has negative earnings and hence a negative payout ratio. The dividend may be in danger.

DP-3.29%

EPS Next 2Y13.5%

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42

NASDAQ:DHCNI (5/23/2025, 9:27:58 PM)

15.3

-0.11 (-0.71%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)05-05 2025-05-05/amc

Earnings (Next)07-30 2025-07-30/amc

Inst Owners75.97%

Inst Owner ChangeN/A

Ins Owners0.35%

Ins Owner ChangeN/A

Market Cap3.69B

Analysts48

Price Target20.45 (33.66%)

Short Float %0%

Short Ratio0.4

Dividend

		Industry Rank	Sector Rank
Dividend Yield	1.27%

Yearly Dividend0.04

Dividend Growth(5Y)-45.6%

DP-3.29%

Div Incr Years0

Div Non Decr Years3

Ex-Date04-15 2025-04-15 (0.3515625)

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)49.8%

Min EPS beat(2)-22.91%

Max EPS beat(2)122.5%

EPS beat(4)2

Avg EPS beat(4)45.86%

Min EPS beat(4)-23.76%

Max EPS beat(4)122.5%

EPS beat(8)3

Avg EPS beat(8)21.36%

EPS beat(12)4

Avg EPS beat(12)5.31%

EPS beat(16)5

Avg EPS beat(16)-4.23%

Revenue beat(2)1

Avg Revenue beat(2)0.64%

Min Revenue beat(2)-0.04%

Max Revenue beat(2)1.32%

Revenue beat(4)1

Avg Revenue beat(4)-0.58%

Min Revenue beat(4)-2.43%

Max Revenue beat(4)1.32%

Revenue beat(8)2

Avg Revenue beat(8)-0.78%

Revenue beat(12)4

Avg Revenue beat(12)-0.58%

Revenue beat(16)4

Avg Revenue beat(16)-1.37%

PT rev (1m)80.92%

PT rev (3m)-13.41%

EPS NQ rev (1m)-10%

EPS NQ rev (3m)4.35%

EPS NY rev (1m)20.51%

EPS NY rev (3m)32.61%

Revenue NQ rev (1m)0.74%

Revenue NQ rev (3m)-0.46%

Revenue NY rev (1m)0.13%

Revenue NY rev (3m)0.38%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	2.44
P/FCF	N/A
P/OCF	45.92
P/B	1.89
P/tB	1.89
EV/EBITDA	25.75

EPS(TTM)-0.64

EYN/A

EPS(NY)-0.75

Fwd EYN/A

FCF(TTM)-0.47

FCFYN/A

OCF(TTM)0.33

OCFY2.18%

SpS6.27

BVpS8.07

TBVpS8.07

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-5.86%
ROE	-15.04%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	17.75%
FCFM	N/A

ROA(3y)-4.29%

ROA(5y)-2.48%

ROE(3y)-10.69%

ROE(5y)-6.22%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.33%

GM growth 5Y-20.05%

F-Score7

Asset Turnover0.3

Health

		Industry Rank	Sector Rank
Debt/Equity	1.44
Debt/FCF	N/A
Debt/EBITDA	11.65
Cap/Depr	68.74%
Cap/Sales	12.88%
Interest Coverage	N/A
Cash Conversion	33.45%
Profit Quality	N/A
Current Ratio	7.4
Quick Ratio	7.4
Altman-Z	0.31

F-Score7

WACC7.08%

ROIC/WACCN/A

Cap/Depr(3y)103.34%

Cap/Depr(5y)92.72%

Cap/Sales(3y)19.78%

Cap/Sales(5y)17.46%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)39.62%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%113.89%

EPS Next Y40.36%

EPS Next 2Y13.5%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)5.33%

Revenue growth 3Y2.63%

Revenue growth 5Y7.53%

Sales Q2Q%4.34%

Revenue Next Year4.86%

Revenue Next 2Y5.67%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y44.97%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year369.96%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y71.86%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y397.18%

OCF growth 3YN/A

OCF growth 5Y-15.84%

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens